BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide (15 amino acids: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) derived from a protective protein found in gastric juice. This peptide has been extensively studied for its potential effects on tissue repair and regeneration processes, making it one of the most researched recovery peptides available.

Research indicates BPC-157 may influence angiogenesis through modulation of vascular endothelial growth factor (VEGF) pathways and nitric oxide production. Studies have examined its effects on fibroblast migration, collagen formation, and inflammatory cytokine expression in various tissue types including tendon, muscle, bone, and intestinal tissue. A notable characteristic of BPC-157 is its stability in gastric acid, which allows for systemic effects following oral administration — an unusual property for peptides.

Pure Pharm Peptides' BPC-157 is verified at 99.078% purity at 10mg/vial, providing researchers with a generous quantity for extended research protocols.

Research Applications:

• Tissue repair and regeneration mechanism studies
• Angiogenesis and VEGF pathway research
• Tendon and ligament healing investigations
• Gastrointestinal tissue repair studies
• Inflammatory cytokine modulation research
• Nitric oxide pathway and vascular biology studies

Key Specifications:

• Purity: 99.078% verified by third-party testing
• Dosage: 10mg per vial
• Category: Recovery
• Storage: -20°C or colder (lyophilized)
• Stability: Up to 2 years when stored properly

Research Highlights:

• 99.078% purity verified by independent third-party HPLC analysis
• 10mg/vial — generous quantity for extended research protocols
• Stable in gastric acid — active via multiple administration routes
• VEGF pathway modulation and angiogenesis promotion
• Molecular weight: 1,419.5 Da | CAS: 137525-51-0 | PubChem CID: 9941957